Free Trial

Theriva Biologics (TOVX) Short Interest Ratio & Short Volume

Theriva Biologics logo
$1.28 +0.02 (+1.59%)
(As of 11/21/2024 ET)

Theriva Biologics Short Interest Data

Theriva Biologics (TOVX) has a short interest of 91,000 shares, representing 4.10% of the float (the number of shares available for trading by the public). This marks a 15.19% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 982,432 shares to cover all short positions.

Current Short Interest
91,000 shares
Previous Short Interest
79,000 shares
Change Vs. Previous Month
+15.19%
Dollar Volume Sold Short
$0.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
2,780,000 shares
Float Size
2,220,000 shares
Short Percent of Float
4.10%
Today's Trading Volume
53,189 shares
Average Trading Volume
982,432 shares
Today's Volume Vs. Average
5%
Short Selling Theriva Biologics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Theriva Biologics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TOVX Short Interest Over Time

TOVX Days to Cover Over Time

TOVX Percentage of Float Shorted Over Time

Theriva Biologics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202491,000 shares $0.00 +15.2%4.1%0 $0.00
10/15/202479,000 shares $0.00 -18.5%3.6%0 $0.00
9/30/202496,900 shares $0.00 +6.5%4.4%0.1 $0.00
9/15/202491,000 shares $0.00 -62.9%6.8%0.2 $0.00
8/31/2024245,200 shares $0.00 +6,030.0%24.8%0.4 $0.00
8/15/20244,000 shares $0.00 -91.4%0.0%0.1 $0.00
7/31/202446,300 shares $0.00 +60.2%0.3%0.1 $0.00
7/15/202428,900 shares $0.00 -93.7%0.2%0 $0.00
6/30/2024457,800 shares $0.00 -21.7%2.7%0.8 $0.00
6/15/2024584,300 shares $0.00 -14.5%3.5%1 $0.00
5/31/2024683,200 shares $0.00 +67.7%4.0%1.2 $0.00
5/15/2024407,300 shares $0.00 -18.3%2.4%0.8 $0.00
4/30/2024498,600 shares $0.00 +26.3%3.0%3.3 $0.00
4/15/2024394,800 shares $0.00 -3.9%2.4%3 $0.00
3/31/2024411,000 shares $0.00 +13.4%2.5%4.2 $0.00
3/15/2024362,600 shares $0.00 +4.1%2.2%3.3 $0.00
2/29/2024348,200 shares $0.00 +0.7%2.1%5.4 $0.00
2/15/2024345,800 shares $0.00 -1.0%2.1%5.2 $0.00
1/31/2024349,100 shares $0.00 -4.2%2.1%5 $0.00
1/15/2024364,500 shares $0.00 +5.4%2.2%6.1 $0.00
12/31/2023345,800 shares $0.00 -8.4%2.1%5.8 $0.00
12/15/2023377,400 shares $0.00 -2.0%2.3%6.9 $0.00
11/30/2023384,900 shares $0.00 +9.4%2.3%8.7 $0.00
11/15/2023351,900 shares $0.00 -14.9%2.1%8.2 $0.00
10/31/2023413,400 shares $0.00 -3.5%2.5%8.9 $0.00
10/15/2023428,200 shares $0.00 +5.6%2.6%7.2 $0.00
9/30/2023405,600 shares $0.00 -14.6%2.4%5.4 $0.00
9/15/2023474,800 shares $0.00 +8.1%2.8%0.6 $0.00
8/31/2023439,100 shares $0.00 +5.9%2.6%0.6 $0.00
8/15/2023414,700 shares $0.00 -5.3%2.5%0.6 $0.00
7/31/2023437,900 shares $0.00 -9.7%3.0%0.6 $0.00
7/15/2023484,700 shares $0.00 -76.5%3.3%0.7 $0.00
6/30/20232,060,000 shares $0.00 +413.1%13.9%3 $0.00
6/15/2023401,500 shares $0.00 +5.8%2.7%5.3 $0.00
5/31/2023379,400 shares $0.00 -1.6%2.6%11.9 $0.00
5/15/2023385,500 shares $0.00 No Change2.6%11.7 $0.00

TOVX Short Interest - Frequently Asked Questions

What is Theriva Biologics' current short interest?

Short interest is the volume of Theriva Biologics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 91,000 shares of TOVX short. 4.10% of Theriva Biologics' shares are currently sold short. Learn More on Theriva Biologics' current short interest.

What is a good short interest percentage for Theriva Biologics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.10% of Theriva Biologics' floating shares are currently sold short.

Is Theriva Biologics' short interest increasing or decreasing?

Theriva Biologics saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 91,000 shares, an increase of 15.2% from the previous total of 79,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Theriva Biologics' float size?

Theriva Biologics currently has issued a total of 2,780,000 shares. Some of Theriva Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Theriva Biologics currently has a public float of 2,220,000 shares.

How does Theriva Biologics' short interest compare to its competitors?

4.10% of Theriva Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Theriva Biologics: Cingulate Inc. (4.35%), Exicure, Inc. (4.71%), Oncotelic Therapeutics, Inc. (0.00%), NLS Pharmaceutics Ltd. (1.27%), Sensei Biotherapeutics, Inc. (1.18%), Sol-Gel Technologies Ltd. (0.39%), ImmunoPrecise Antibodies Ltd. (3.05%), Antibe Therapeutics Inc. (0.12%), Talphera, Inc. (0.60%), BetterLife Pharma Inc. (0.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Theriva Biologics stock?

Short selling TOVX is an investing strategy that aims to generate trading profit from Theriva Biologics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Theriva Biologics?

A short squeeze for Theriva Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TOVX, which in turn drives the price of the stock up even further.

How often is Theriva Biologics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TOVX, twice per month. The most recent reporting period available is October, 31 2024.




This page (NYSEAMERICAN:TOVX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners